Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mayne Pharma Group ( (AU:MYX) ) has provided an announcement.
Insignia Financial Ltd has announced that it has ceased to be a substantial holder in Mayne Pharma Group Limited as of March 4, 2025. The notice details various transactions involving the purchase and sale of shares by Insignia Financial Ltd and its subsidiaries, indicating a significant reduction in their holdings in Mayne Pharma. This change in substantial holding may impact Mayne Pharma’s shareholder structure and could influence its market perception and stock performance.
More about Mayne Pharma Group
YTD Price Performance: 53.65%
Average Trading Volume: 2,239
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $369.2M
For detailed information about MYX stock, go to TipRanks’ Stock Analysis page.